[Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D005260:Female; D007942:Leukemia, Experimental / Q000188:drug therapy; D007958:Leukocyte Count; D008221:Lymphoid Tissue / Q000187:drug effects*; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008558:Melphalan / Q000494:pharmacology; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009929:Organ Size; D010051:Ovarian Neoplasms / Q000188:drug therapy; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013154:Spleen / Q000187:drug effects; D013160:Splenic Neoplasms / Q000188:drug therapy; D013950:Thymus Gland / Q000187:drug effects; D013953:Thymus Neoplasms / Q000188:drug therapy; D013997:Time Factors; D014227:Triazines / Q000494:pharmacology
D000970:Antineoplastic Agents; D014227:Triazines; D008558:Melphalan
Izmenenie vesa nekotorykh limfoidnykh organov kak kriteriĭ toksicheskogo deĭstviia protivoopukholevykh preparatov